Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Maria Frezza

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Cancer|November 16, 2020
Long-term outcomes of pexidartinib in tenosynovial giant cell tumorsHans Gelderblom, Andrew J Wagner, William D Tap, et al.
Cancers|July 24, 2019
Comparative Assessment of Antitumor Effects and Autophagy Induction as a Resistance Mechanism by Cytotoxics and EZH2 Inhibition in INI1-Negative Epithelioid Sarcoma Patient-Derived XenograftSilvia Stacchiotti, Valentina Zuco, Monica Tortoreto, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2014
Mesenchymal chondrosarcoma: prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society studyAnna Maria Frezza, Marilena Cesari, Daniel Baumhoer, et al.
The Oncologist|June 26, 2020
The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors: A Multicenter, European Retrospective Case Series AnalysisGiacomo Giulio Baldi, Mehdi Brahmi, Salvatore Lo Vullo, et al.
Cancer Medicine|July 18, 2022
CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 studyAnna Maria Frezza, Silvia Stacchiotti, Frederic Chibon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 4, 2024
Proximal and Classic Epithelioid Sarcomas are Distinct Molecular Entities Defined by MYC/GATA3 and SOX17/Endothelial Markers, RespectivelyLuca Sigalotti, Anna Maria Frezza, Marta Sbaraglia, et al.
Journal of Neuroendocrinology|November 19, 2025
Bone metastases from neuroendocrine neoplasms: Results of an Italian nationwide survey of natural history and managementNicola Fazio, Patrick Maisonneuve, Anna Maria Frezza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2023
Translational Aspects of Epithelioid Sarcoma: Current ConsensusThomas G P Grünewald, Sophie Postel-Vinay, Robert T Nakayama, et al.
The Lancet Regional Health. Europe|February 22, 2024
Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACANJean-Yves Blay, Paolo Casali, Isabelle Ray-Coquard, et al.
The Lancet. Oncology|July 24, 2019
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trialSilvia Stacchiotti, Stefano Ferrari, Andres Redondo, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Cancer|November 16, 2020
Long-term outcomes of pexidartinib in tenosynovial giant cell tumorsHans Gelderblom, Andrew J Wagner, William D Tap, et al.
Cancers|July 24, 2019
Comparative Assessment of Antitumor Effects and Autophagy Induction as a Resistance Mechanism by Cytotoxics and EZH2 Inhibition in INI1-Negative Epithelioid Sarcoma Patient-Derived XenograftSilvia Stacchiotti, Valentina Zuco, Monica Tortoreto, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2014
Mesenchymal chondrosarcoma: prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society studyAnna Maria Frezza, Marilena Cesari, Daniel Baumhoer, et al.
The Oncologist|June 26, 2020
The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors: A Multicenter, European Retrospective Case Series AnalysisGiacomo Giulio Baldi, Mehdi Brahmi, Salvatore Lo Vullo, et al.
Cancer Medicine|July 18, 2022
CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 studyAnna Maria Frezza, Silvia Stacchiotti, Frederic Chibon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 4, 2024
Proximal and Classic Epithelioid Sarcomas are Distinct Molecular Entities Defined by MYC/GATA3 and SOX17/Endothelial Markers, RespectivelyLuca Sigalotti, Anna Maria Frezza, Marta Sbaraglia, et al.
Journal of Neuroendocrinology|November 19, 2025
Bone metastases from neuroendocrine neoplasms: Results of an Italian nationwide survey of natural history and managementNicola Fazio, Patrick Maisonneuve, Anna Maria Frezza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2023
Translational Aspects of Epithelioid Sarcoma: Current ConsensusThomas G P Grünewald, Sophie Postel-Vinay, Robert T Nakayama, et al.
The Lancet Regional Health. Europe|February 22, 2024
Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACANJean-Yves Blay, Paolo Casali, Isabelle Ray-Coquard, et al.
The Lancet. Oncology|July 24, 2019
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trialSilvia Stacchiotti, Stefano Ferrari, Andres Redondo, et al.
Pageof 7